Working Groups

To advance our understanding of the mechanisms at work within the biotech and pharma industries, we have convened working groups that bring together individuals from key stakeholder communities including financial institutions, institutional investors, foundations and endowments, and local-area academic medical centers and university research laboratories. Working group meetings provide a forum to to engage in active dialogue regarding specific funding needs, potential business and legal structures for pooling intellectual property, and new sources of capital to fund such portfolios. Participants have the opportunity to learn more about specific projects and R&D efforts, funding opportunities, and potential financing methods for attracting capital.

NIH National Center for Advancing Translational Sciences (NCATS) Working Group

New Funding Models for Translational Medicine: The Boston/Cambridge BioFinance Working Group

Creating a California Cancer Megafund: The Caltech/MIT BioFinance Working Group